InSpace Accelerated Rehabilitation Study
Stryker Endoscopy · NCT05329584
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 160
- US sites recruiting
- 11
- Study start
- February 7, 2022
- Record last updated
- May 29, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a prospective, parallel group, open-label, multi- center, randomized study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.
Being studied: InSpace Subacromial Tissue Spacer
Conditions: Rotator Cuff Tears
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Subjects MUST meet ALL the following criteria to be included in the study:
- The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment
- Is male or female ≥ sixty-five (65) years of age
- Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT:
- Measuring ≥ 5 cm in diameter
- Involving ≥ two tendons
- Functional deltoid muscle and preserved passive range of motion on physical examination
- Documented VAS score > 30 mm pain
- Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following:
- Oral analgesics
- Anti-inflammatory medication (e.g., ibuprofen, naproxen)
- Corticosteroid injection(s)
- Physical therapy
- Activity modification
- Rest (sling used)
- Must be able to read and understand the approved Informed Consent Form (written and oral)
- Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
- Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection
Intra-operative Inclusion Criteria
Subjects MUST meet the following criteria to be randomized in the study:
- Full thickness tear
- Tear size ≥ 5 cm in diameter
- Tear involving ≥ two tendons
Exclusion Criteria
Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:
- Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)
- Evidence of the following conditions:
- Severe gleno-humeral or acromio-humeral arthritis
- Full thickness cartilage loss as seen on MRI
- History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings
- Pre-existing deltoid defect or deltoid palsy
- Major joint trauma, infection, or necrosis
- Partial thickness tears of the supraspinatus
- Fully reparable rotator cuff tear [Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired]
- Known neurovascular compromise
- Complete deltoid muscle palsy
- Traumatic muscle tears of the pectoralis or deltoid
- The subject requires concomitant:
- Subscapularis repair
- Labral repair of any type
- Biceps tenodesis
- Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
- The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder
- Major medical condition that could affect quality of life and influence the results of the study (e.g., rheumatoid arthritis)
- The subject has documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment
- The subject's condition represents a worker's compensation case
- The subject is currently involved in a health-related litigation procedure
- Females of child-bearing potential who are pregnant or plan to become pregnant.
- Concurrent participation in an investigational clinical study one month prior to enrollment or during the entire study period
- The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up
- The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition
- The subject currently has an acute infection in the area surrounding the surgical site.
- Baseline WORC score less than 420
Intra-operative Exclusion Criteria
Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:
- Rotator cuff is/presents with:
- Fully reparable with adequate tissue and muscle quality (equivalent to Goutallier stage 1 or 2)
- Partial thickness tear of the supraspinatus
- Evidence of significant osteoarthritis
- The subject requires concomitant:
- Subscapularis repair
- Labral repair of any type
- Biceps tenodesis
- Coracoacromial ligament functional deficiency or shoulder instability is identified
Recruiting US locations
Musculoskeletal-Orthopedic Research and Education Foundation
Phoenix, AZ 85023
Site contact: Wafa Mohsin · wafa.mohsin@more-foundation.org
University of Arkansas for Medical Sciences
Little Rock, AR 72205
Site contact: Dana Garrison · DLGarrison@uams.edu
Steadman Hawkins Clinic Denver
Englewood, CO 80112
Site contact: Lauren Heylmun · LAUREN.HEYLMUN@CUANSCHUTZ.EDU
Holy Cross Hospital
Fort Lauderdale, FL 33308
Site contact: David Henderson · David.Henderson002@holy-cross.com
Paley Orthopaedics & Spine
West Palm Beach, FL 33407
Site contact: Janice Schuck · janice.schuck@tenehealth.com
Emory University
Atlanta, GA 30329
Site contact: Isabelle Vernon · isabelle.m.vernon@emory.edu
Rush University Medical Center
Chicago, IL 60612
Site contact: Kavita Ahuja · kavita.ahuja@rushortho.com
Mayo Clinic
Rochester, MN 55905
Site contact: Lindsey Hobbs · hobbs.lindsey@mayo.edu
Hospital for Special Surgery
New York, NY 10021
Site contact: Anthony Finocchiaro · finocchiaroa@hss.edu
The Rothman Institute
Philadelphia, PA 19107
Site contact: Thema Nicholson · thema.nicholson@rothmanortho.com
TSAOG Orthopaedics & Spine
San Antonio, TX 78258
Site contact: Amanda Strickland · astrickland@brioresearch.org
Study contacts (from the official record)
- Hayley Taylor, MS · 805-705-4206 · hayley.taylor@stryker.com
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55